Document text
Principal Investigator: Richard G Kibbey
Organization: YALE UNIVERSITY
Fiscal Year: 2024
Award: $730,784
Funding agency: National Institute of Diabetes and Digestive and Kidney Diseases
Ongoing analyses from our laboratory and others have identified novel properties of self proteins, namely
posttranslational protein modifications (PTMs) that may be identified as early proteomic and immunologic
biomarkers of Type 1 diabetes as well as alter metabolic pathways. An emerging number of self proteins
acquire PTMs and become targets of B and T cell autoimmune responses leading to inflammation and
pathology in the pancreas. Some examples of critical modifications to self proteins include citrullination,
oxidation, deamidation reactions, and isoaspartyl modification, all responses of self proteins within cells that
undergo inflammatory stress. Key PTM candidates have already been identified from human beta cells and
other key candidates will be identified from beta cell derived exosomes, recently identified as a peripheral
marker of beta cell health. As importantly, these PTMs within cells may alter the biological properties of
proteins within beta cells. In the present proposal, we will define how modified self-proteins may alter
enzymatic pathways of glucose sensing and insulin secretion in the pancreatic beta cell. The proposal will
utilize MultiOrdinate Spectral Analysis (MIMOSA), a technology pioneered at Yale University. MIMOSA is a
major innovation that provides an internally cross-validated as well as NMR-validated, direct, rigorous,
comprehensive integrated analysis of metabolic fluxes. The “multi-ordinate” aspect of MIMOSA incorporates
the flow of stable isotope from metabolite to metabolite along intersecting metabolic pathways. The “mass
isotopomer” aspect uses MS/MS-based ion fragmentation analysis of stable-isotope-labeled metabolites to
identify the carbon-specific position of label. The significance and innovation of the present studies is in
identifying pathways that may restore beta cell functions, via pharmaceutical correction of the aberrant
modification, as well as link autoimmune biomarkers with pathways of beta cell dysfunction.
Terms: <Active Oxygen><Affect><Antibodies><Appearance><Asparagine><Aspartic Acid><Assay><Attention><Autoimmune><Autoimmune Diseases><Autoimmune Responses><Autoimmune Status><Autoimmune biomarker><Autoimmune disease biomarker><Autoimmunity><Autoimmunity biomarker><Autoimmunity marker><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><B9 endocrine pancreas><Beta Cell><Binding Sites><Bioassay><Biochemical><Biological><Biological Assay><Biological Markers><Body Tissues><Brittle Diabetes Mellitus><Carbon><Cell Body><Cell Function><Cell Physiology><Cell Process><Cells><Cellular Function><Cellular Metabolic Process><Cellular Physiology><Cellular Process><Characteristics><Chronic><Citrulline><Clinical><Combining Site><D-Glucose><Data><Development><Dextrose><Dysfunction><Endocrine Pancreas><Enzyme Gene><Enzymes><Exposure to><Extracellular Space><Functional disorder><Glucokinase><Glucose><Glycolysis><Health><Human><Human Figure><Human body><Humulin R><IDDM><Immune Markers><Immune response><Immunity><Immunologic Markers><Immunological response><In Vitro><Individual><Inflammation><Inflammatory><Insulin><Insulin Cell><Insulin Secreting Cell><Insulin-Dependent Diabetes Mellitus><Intercellular Space><Intermediary Metabolism><Ions><Islands of Langerhans><Islets of Langerhans><Isoaspartic Acid><Isoforms><Juvenile-Onset Diabetes Mellitus><Ketosis-Prone Diabetes Mellitus><L-Asparagine><L-Aspartic Acid><Label><Laboratories><Link><Location><Maps><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Metabolic><Metabolic Glycosylation><Metabolic Pathway><Metabolic Processes><Metabolic dysfunction><Metabolism><Mice><Mice Mammals><Mind><Modern Man><Modification><Molecular Modeling Nucleic Acid Biochemistry><Molecular Modeling Protein/Amino Acid Biochemistry><Molecular Models><Murine><Mus><Nesidioblasts><Novolin R><Outcome><Oxygen Radicals><Pancreas><Pancreatic><Pancreatic Islets><Pancreatic beta Cell><Pancreatic β-Cell><Pars endocrina pancreatis><Pathology><Pathway interactions><Patients><Peptide/Protein Chemistry><Peptides><Peripheral><Pharmaceutical Agent><Pharmaceuticals><Pharmacologic Substance><Pharmacological Substance><Phosphorylation><Physiopathology><Pilot Projects><Position><Positioning Attribute><Post-Translational Modification Protein/Amino Acid Biochemistry><Post-Translational Modifications><Post-Translational Protein Modification><Post-Translational Protein Processing><Posttranslational Modifications><Posttranslational Protein Processing><Pro-Oxidants><Process><Production><Property><Protein Chemistry><Protein Isoforms><Protein Modification><Protein Phosphorylation><Proteins><Proteome><Proteomics><Reaction><Reactive Oxygen Species><Reactive Site><Regular Insulin><Sentinel><Serology><Shapes><Site><Stable Isotope Labeling><Stress><Structure><Structure of beta Cell of islet><Subcellular Process><Sudden-Onset Diabetes Mellitus><T cell response><T-Cells><T-Lymphocyte><T1 DM><T1 diabetes><T1D><T1DM><Technology><Therapeutic><Time><Tissues><Type 1 Diabetes Mellitus><Type 1 diabetes><Type I Diabetes Mellitus><Universities><Work><autoimmune condition><autoimmune disorder><autoimmunity disease><beta-Aspartic Acid><bio-markers><biologic><biologic marker><biomarker><biomarker against autoimmune disease><biomarker in autoimmune disease><cell metabolism><cellular metabaolism><cytokine><deamidation><developmental><early onset><exosome><glycosylation><hiPSC><host response><human iPS><human iPSC><human induced pluripotent cell><human induced pluripotent stem cells><human inducible stem cells><iPS><iPSC><iPSCs><immune system response><immune-based biomarkers><immunogenic><immunological biomarkers><immunological markers><immunoresponse><induced human pluripotent stem cells><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent stem cell><inhibitor><innovate><innovation><innovative><insulin dependent diabetes><insulin dependent type 1><insulin secretion><islet><islet progenitor><juvenile diabetes><juvenile diabetes mellitus><ketosis prone diabetes><mitochondrial metabolism><molecular modeling><neo-antigen><neo-epitopes><neoantigens><neoepitopes><non-diabetic><nondiabetic><novel><oxidation><pancreas beta cell><pancreas β cell><pancreatic b-cell><pathophysiology><pathway><pharmaceutical><pilot study><repair><repaired><response><stable isotope><thymus derived lymphocyte><type I diabetes><type one diabetes><β-cell><β-cells><βCell>